Bridgepoint Group (LON:BPT) Trading 1.6% Higher – Here’s What Happened

Bridgepoint Group plc (LON:BPTGet Free Report) was up 1.6% during mid-day trading on Wednesday . The company traded as high as GBX 276.80 and last traded at GBX 268.55. Approximately 944,432 shares traded hands during trading, a decline of 82% from the average daily volume of 5,388,044 shares. The stock had previously closed at GBX 264.40.

Analyst Ratings Changes

Separately, Citigroup lowered their price objective on Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of GBX 385.

View Our Latest Stock Report on BPT

Bridgepoint Group Price Performance

The company has a 50 day moving average price of GBX 251.36 and a 200 day moving average price of GBX 265.18. The firm has a market cap of £2.35 billion, a PE ratio of 54.81, a price-to-earnings-growth ratio of 0.61 and a beta of 1.36. The company has a current ratio of 279.03, a quick ratio of 3.60 and a debt-to-equity ratio of 55.04.

Bridgepoint Group (LON:BPTGet Free Report) last announced its quarterly earnings results on Thursday, March 12th. The company reported GBX 26.50 EPS for the quarter. Bridgepoint Group had a return on equity of 4.25% and a net margin of 7.68%. On average, sell-side analysts expect that Bridgepoint Group plc will post 17.4062165 EPS for the current year.

Insider Activity at Bridgepoint Group

In other news, insider Michelle Scrimgeour purchased 21,616 shares of the firm’s stock in a transaction dated Thursday, March 12th. The shares were acquired at an average price of GBX 230 per share, with a total value of £49,716.80. 0.60% of the stock is owned by company insiders.

Bridgepoint Group Company Profile

(Get Free Report)

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

Featured Stories

Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.